ECM
AGIO icon

ExodusPoint Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

ExodusPoint Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-71,146
Closed -$1.94M – 1514
2025
Q4 		$1.94M Buy
+71,146
New +$2.5M 0.02% 779
2025
Q2 		– Sell
-10,553
Closed -$309K – 1423
2025
Q1 		$309K Buy
+10,553
New +$350K ﹤0.01% 1222
2024
Q2 		– Sell
-101,612
Closed -$2.97M – 1477
2024
Q1 		$2.97M Buy
101,612
+498
+0.5% +$13.3K 0.02% 559
2023
Q4 		$2.25M Buy
+101,114
New +$2.27M 0.01% 543
2023
Q3 		– Sell
-120,363
Closed -$3.41M – 1648
2023
Q2 		$3.41M Sell
120,363
-78,003
-39% -$1.94M 0.03% 591
2023
Q1 		$4.56M Buy
198,366
+184,341
+1,314% +$4.9M 0.04% 545
2022
Q4 		$394K Buy
+14,025
New +$395K 0.01% 1266
2022
Q3 		– Sell
-60,238
Closed -$1.33M – 1840
2022
Q2 		$1.33M Sell
60,238
-106,221
-64% -$2.4M 0.02% 952
2022
Q1 		$4.85M Buy
166,459
+155,287
+1,390% +$4.74M 0.06% 399
2021
Q4 		$367K Sell
11,172
-13,806
-55% -$556K ﹤0.01% 1569
2021
Q3 		$1.15M Buy
24,978
+21,016
+530% +$1.02M 0.02% 962
2021
Q2 		$218K Sell
3,962
-64,711
-94% -$3.62M ﹤0.01% 1929
2021
Q1 		$3.55M Sell
68,673
-2,928
-4% -$145K 0.05% 378
2020
Q4 		$3.1M Buy
71,601
+41,829
+140% +$1.65M 0.03% 387
2020
Q3 		$1.04M Sell
29,772
-30,136
-50% -$1.32M 0.02% 660
2020
Q2 		$3.2M Buy
+59,908
New +$2.77M 0.08% 273
2019
Q2 		– Sell
-12,621
Closed -$851K – 1068
2019
Q1 		$851K Buy
+12,621
New +$735K 0.06% 216

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

ExodusPoint Capital Management's AGIO Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 71,146 shares — an estimated $1.94M sold.

ExodusPoint Capital Management first reported a position in AGIO in Q1 2019 and held it in 17 quarters. The position peaked at $4.85M in Q1 2022. 234 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 71,146 Agios Pharmaceuticals shares in Q1 2026, an estimated $1.94M.
  • ExodusPoint Capital Management first reported a position in Agios Pharmaceuticals in Q1 2019 and held it in 17 quarters.
  • ExodusPoint Capital Management's Agios Pharmaceuticals position peaked at $4.85M in Q1 2022.
  • 234 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.